N.V.E. Pharmaceuticals, Inc. FDA Inspection Record
N.V.E. Pharmaceuticals, Inc. is an FDA-inspected facility (FEI 3000205552) located in Andover, NJ, US. RegDataLab tracks 6 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Mar 20, 2026: No Action Indicated (NAI)
- Inspections on record
- 6 (2 OAI, 1 VAI, 3 NAI)
- Last OAI inspection
- Dec 16, 2015
- Warning letters
- 1 listed by FDA for this FEI, latest Jul 22, 2013
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 20, 2026 | No Action Indicated (NAI) | No citations listed |
| May 24, 2023 | No Action Indicated (NAI) | No citations listed |
| Dec 14, 2016 | Voluntary Action Indicated (VAI) | Specifications met - verify; finished batch (21 CFR 111.75(c)) |
| Dec 16, 2015 | Official Action Indicated (OAI) | No citations listed |
| Apr 22, 2014 | No Action Indicated (NAI) | No citations listed |
| Sep 26, 2012 | Official Action Indicated (OAI) | Instruments - calibration (21 CFR 111.27(b)) Equipment - design - suitable (21 CFR 111.27(a)) Hold - temperature, humidity, light (21 CFR 111.455(a)) Manufacturing operations - prevent contamination (21 CFR 111.365) and 7 more |
FDA record score
2 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
4 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Dec 14, 2016 | 6 x 0.25 | 1.5 |
| Inspection classified OAI | Dec 16, 2015 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Jul 22, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Sep 26, 2012 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing N.V.E. Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check N.V.E. Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- NVE Pharmaceuticals, Inc.
- Location
- Andover, NJ (US)
- Source
- inspections